Global Tumor Profiling Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Tumor Profiling Industry By The Forecast Year 2029?

The tumor profiling market has experienced substantial expansion in recent years. Projections indicate it will expand from $10.16 billion in 2024 to $11.18 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth can be ascribed to factors such as the increasing incidence of cancer, the growing need for personalized medicine, rising healthcare spending, greater use of companion diagnostics, and enhanced awareness regarding the early detection of cancer.

The tumor profiling market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $16.37 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.0%. This growth during the forecast period can be primarily attributed to the increasing embrace of liquid biopsy methods, heightened investment in cancer research and development, an expanding elderly population, the widespread use of targeted therapies, and a rise in collaborative cancer research efforts. Key trends anticipated for this period encompass a move towards companion diagnostics, an uptick in multi-gene testing, technological improvements in next-generation sequencing, the incorporation of artificial intelligence (AI) into cancer diagnostics, and progress in tumor profiling technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

What Are The Top Growth Drivers Impacting The Tumor Profiling Market Outlook?

The growing need for personalized medicine is anticipated to fuel the expansion of the tumor profiling market going forward. Personalized medicine represents an approach that tailors healthcare treatments to the individual characteristics of each patient. This surge in demand is driven by patients actively seeking more precise therapies that promise better outcomes and fewer side effects compared to conventional treatments. Tumor profiling significantly aids personalized medicine by pinpointing specific genetic mutations and biomarkers within a patient’s tumor, thereby enabling targeted treatments and minimizing adverse effects. For instance, in February 2024, a report published by the Personalized Medicine Coalition, a US-based organization dedicated to advancing personalized medicine, indicated that personalized medicines constituted more than one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. Consequently, the escalating demand for personalized medicine is propelling growth in the tumor profiling market.

How Is The Tumor Profiling Market Segmented?

The tumor profilingmarket covered in this report is segmented –

1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics

2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray

3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting

3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)

Which Trends Are Impacting The Tumor Profiling Market?

Leading companies in the tumor profiling market are concentrating on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to enhance the precision and efficiency of cancer treatment. Artificial intelligence (AI) encompasses the application of sophisticated computational methods to analyze complex genomic, proteomic, and clinical data, which facilitates quicker diagnoses, personalized treatment strategies, and improved monitoring of disease progression. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-driven software solution is specifically designed to profile key molecular biomarkers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR) directly from H and E-stained images of colon cancer tissue samples. This digital tool enables rapid and accurate molecular profiling of tumors, which is critical for diagnosing colorectal cancer, identifying cases of Lynch syndrome, and guiding personalized treatment decisions.

Which Key Players Are Driving Competition In The Tumor Profiling Market?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

What Are The Regional Market Dynamics Impacting The Tumor Profiling Industry?

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tumor Profiling Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Browse Through More Reports Similar to the Global Tumor Profiling Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795